Intervention

Nivolumab Injection

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting1

Common conditions10

Lead sponsors shown4

Clinical trials

4 shown

The IMmunotherapy Pleural 5-ALA PDTNCT04400539 · 2022-05-09

Evaluation of AL3818 in Combination With Nivolumab in Solid TumorsNCT04165330 · 2019-10-17

ACTIVE_NOT_RECRUITING

Nivolumab With Chemotherapy in Pleural Mesothelioma After SurgeryNCT04177953 · 2019-02-04

Immunotherapy by Nivolumab for HIV+ PatientsNCT03304093 · 2017-10-19

Common conditions

HIV/AIDS1 Malignant Pleural Mesothelioma1 Mesotheliomas Pleural1 Non Small Cell Lung Cancer1 Non Small Cell Lung Cancer Metastatic1 Non Small Cell Lung Cancer Stage IIIB1 Pleural Mesothelioma Malignant1 Small Cell Lung Cancer1 Soft Tissue Sarcoma1 Solid Tumor, Adult1

Leading sponsors

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1 Intergroupe Francophone de Cancerologie Thoracique1 Sarcoma Oncology Research Center, LLC1 University Hospital, Lille1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

PHASE24

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.